Ivermectin is not effective against hookworm infections in humans. While it works well against several other intestinal parasites, clinical trials have consistently shown very low cure rates for hookworm, making it a poor choice for this particular infection. Albendazole, which cures hookworm in roughly 98% of cases, is the standard treatment.
Why Ivermectin Fails Against Hookworms
Ivermectin kills parasites by locking open specific chloride channels in their nerve and muscle cells. When these channels stay open, chloride ions flood in, the parasite becomes paralyzed, and it eventually dies. This mechanism works extremely well against roundworms, threadworms, and several insect parasites.
The problem with hookworms is that their biology differs in a key way. The two species responsible for most human infections, Necator americanus and Ancylostoma duodenale, lack certain channel subunits that ivermectin typically targets. Without those molecular docking points, the drug has a much weaker grip on the parasite. A clinical study in children found that ivermectin was “ineffective against hookworms,” while albendazole achieved a 98% cure rate in the same group. Some adult worms from both hookworm species were expelled after ivermectin treatment, suggesting the drug has a partial effect, but not nearly enough to clear an infection reliably.
What Works for Hookworm Instead
Albendazole is the first-line treatment for hookworm infections worldwide. A single oral dose is typically all that’s needed, and it eliminates the vast majority of worms. Mebendazole is another option in the same drug class. Both are donated through the WHO to endemic countries for mass deworming programs, and they’ve been the backbone of hookworm control for decades.
The CDC lists ivermectin as a treatment for zoonotic hookworm (the type you pick up from animal larvae penetrating the skin, which causes a condition called cutaneous larva migrans). For that specific scenario, a single dose of 200 mcg/kg can be curative, and additional doses may be needed for severe or relapsing cases with skin inflammation. This is a different situation from an established intestinal hookworm infection, where the worms have matured and are feeding on blood in the gut lining.
Does Adding Ivermectin to Albendazole Help?
Researchers have tested whether combining ivermectin with albendazole improves hookworm treatment. A meta-analysis pooling five studies found no meaningful benefit. The combination achieved an egg reduction rate of 97.7%, while albendazole alone hit 96.8%, a negligible difference. Cure rates were also statistically comparable between the two approaches. In other words, the albendazole is doing the heavy lifting, and ivermectin adds little when it comes to hookworm specifically.
The combination does shine for other parasites. Against threadworm (Strongyloides stercoralis), ivermectin is far superior to albendazole, curing 83% of infections compared to 45%. And against roundworm, both drugs perform well. So in regions where people carry multiple types of intestinal worms at once, combining the two drugs can cover a broader range of parasites. The WHO has been working to make generic ivermectin affordable since 2021 specifically to address Strongyloides, which albendazole and mebendazole don’t treat effectively.
Where Ivermectin Does Excel
It helps to understand where ivermectin fits in the parasite treatment landscape, since its reputation as a powerful dewormer is well earned for certain infections. It is the drug of choice for Strongyloides stercoralis, a threadworm that can persist in the body for decades and become life-threatening in people with weakened immune systems. It’s also the primary tool for controlling river blindness (onchocerciasis) and lymphatic filariasis in mass treatment campaigns across tropical regions.
For hookworm, though, the evidence is consistent: ivermectin alone is not a reliable treatment. If you suspect a hookworm infection based on symptoms like persistent abdominal pain, fatigue, or iron-deficiency anemia after exposure to contaminated soil, albendazole is the treatment you’d expect to receive.
Safety Considerations
When ivermectin is used for the parasites it does treat, it’s generally well tolerated at standard doses. The most notable serious risk involves people co-infected with a parasitic worm called Loa loa, found only in Central Africa. In individuals carrying very high levels of Loa loa larvae in their blood, ivermectin can trigger severe and sometimes fatal brain inflammation. This risk is specific to that co-infection and is the reason mass drug distribution programs in Central Africa require careful screening before administering ivermectin.
For most people outside those regions, side effects from a single dose tend to be mild: nausea, dizziness, or a brief skin rash as dying parasites release proteins that trigger a mild immune response.